Somaxon Slaps Par With 2nd Suit Over Generic Silenor
Somaxon Pharmaceuticals Inc. hit Par Pharmaceutical Cos. Inc. with a patent infringement suit in Delaware on Thursday, seeking to prevent the release of the generic drug maker's version of Somaxon's prescription...To view the full article, register now.
Already a subscriber? Click here to view full article